<DOC>
	<DOCNO>NCT01657188</DOCNO>
	<brief_summary>Prospective , follow-up registry heart failure patient without sleep-disordered breathing ( SDB ) . To test hypothesis treatment nocturnal central sleep apnea Cheyne-Stokes respiration adaptive servoventilation ( ASV ) improve symptom , cardiac performance event-free survival .</brief_summary>
	<brief_title>Effects Adaptive Servoventilation Patients With Systolic Heart Failure Sleep-Disordered Breathing</brief_title>
	<detailed_description>The study intend investigate therapeutic effect adaptive servoventilation patient sleep-disordered breathe chronic heart failure . These effect include short-/long-term effect - symptom quality life - physical cardiac performance ( 6min walk test , cardiopulmonary exercise test ) - echocardiographic parameter - arrhythmias - NT-proBNP - Respiratory stability ( blood gas , rebreathing test , VE/VCO2-slope cardiopulmonary exercise test ) - Compliance ASV therapy - Event free survival ( death , heart transplantation , assist device implantation ) All data also obtain patient basically meet inclusion criterion sleep-disordered breathing exclude mean cardiorespiratory polygraphy polysomnography patient sleep-disordered breathe undergo adaptive servoventilation various reason .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<mesh_term>Heart Failure , Systolic</mesh_term>
	<criteria>Stable heart failure NYHA ≥ II EF ≤ 45 % without sleepdisordered breathing ( apneahypopneaindex &lt; 5/h ) moderate severe central sleep apnea ( apneahypopnea index ≥ 15/h ) without adaptive servoventilation therapy Cardiac resynchronization pacemaker implantation within last 6 month Significant COPD force expiratory onesecond capacity relative vital capacity ( FEV1/VC ) &lt; 70 % ( GOLD III ) Respiratory insufficiency require longterm oxygen therapy Daytime hypercapnia rest ( pCO2 &gt; 45 mmHg ) Current ventilation therapy Cardiac surgery , PCI , myocardial infarction , unstable angina , TIA stroke within 12 week prior randomization Acute myocarditis within 6 month prior randomization Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Heart failure , congestive</keyword>
	<keyword>Sleep apnea syndrome</keyword>
	<keyword>Adaptive servoventilation</keyword>
	<keyword>Prognosis</keyword>
	<keyword>Cheyne-Stokes respiration</keyword>
</DOC>